The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2

被引:134
作者
Li, Wenhui
Sui, Jianhua
Huang, I-Chueh
Kuhn, Jens H.
Radoshitzky, Sheli R.
Marasco, Wayne A.
Choe, Hyeryun
Farzan, Michael
机构
[1] Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA
[2] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA
[3] Free Univ Berlin, Dept Biol, D-1000 Berlin, Germany
[4] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[5] Childrens Hosp, Ina Sue Perlmutter Lab, Boston, MA 02115 USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
human coronavirus NL63; SARS coronavirus; angiotensin-converting enzyme 2; viral entry;
D O I
10.1016/j.virol.2007.04.035
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The cellular receptor for human coronavirus NL63 (HCoV-NL63), a group I coronavirus, is angiotensin-converting enzyme2 (ACE2). ACE2 is also the receptor for the SARS coronavirus (SARS-CoV), a group It coronavirus. Here we describe the ability of HCoV-NL63 to utilize a number of ACE2 variants previously characterized as SARS-CoV receptors. Several ACE2 variants that reduced SARS-CoV S-protein association similarly reduced that of HCoV-NL63, whereas alteration of a number of solvent-exposed ACE2 residues did not interfere with binding by either S protein. One notable exception is ACE2 residue 354, at the boundary of the SARS-CoV binding site, whose alteration markedly inhibited utilization by the HCoV-NL63 but not SARS-CoV S proteins. In addition, the SARS-CoV S-protein receptor-binding domain inhibited entry mediated by the HCoV-NL63 S protein. These studies indicate that HCoV-NL63, like SARS-CoV, associates region of human ACE2 that includes a key loop formed by beta-strands 4 and 5. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:367 / 374
页数:8
相关论文
共 46 条
[41]   A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2 [J].
Wong, SK ;
Li, WH ;
Moore, MJ ;
Choe, H ;
Farzan, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (05) :3197-3201
[42]   Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia [J].
Woo, PCY ;
Lau, SKP ;
Tsoi, HW ;
Huang, Y ;
Poon, RWS ;
Chu, CM ;
Lee, RA ;
Luk, WK ;
Wong, GKM ;
Wong, BHL ;
Cheng, VCC ;
Tang, BSF ;
Wu, AKL ;
Yung, RWH ;
Chen, HL ;
Guan, Y ;
Chan, KH ;
Yuen, KY .
JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (11) :1898-1907
[43]   The SARS-CoV S glycoprotein [J].
Xiao, X ;
Dimitrov, DS .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (19-20) :2428-2430
[44]   The SARS-CoV S glycoprotein: expression and functional characterization [J].
Xiao, XD ;
Chakraborti, S ;
Dimitrov, AS ;
Gramatikoff, K ;
Dimitrov, DS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 312 (04) :1159-1164
[45]   HUMAN AMINOPEPTIDASE-N IS A RECEPTOR FOR HUMAN CORONAVIRUS-229E [J].
YEAGER, CL ;
ASHMUN, RA ;
WILLIAMS, RK ;
CARDELLICHIO, CB ;
SHAPIRO, LH ;
LOOK, AT ;
HOLMES, KV .
NATURE, 1992, 357 (6377) :420-422
[46]  
Zhong NS, 2003, CHINESE MED J-PEKING, V116, P803